Difference between revisions of "Lodewijk J. R. de Vink"
m (Text replacement - "|twitter= " to "") |
(unstub) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{person | {{person | ||
|wikipedia= | |wikipedia= | ||
| + | |prabook=https://prabook.com/web/lodewijk_j.r.de.vink/69784 | ||
|zoominfo=http://www.zoominfo.com/p/Lodewijk-De+Vink/8038684 | |zoominfo=http://www.zoominfo.com/p/Lodewijk-De+Vink/8038684 | ||
| − | | | + | |description=Dutch Bilderberger [[Big Pharma]] executive |
| − | |nationality= | + | |alma_mater=Washburn University, Nyenrode Business University, American University/Kogod School of Business |
| − | |birth_date= | + | |nationality=Dutch,US |
| + | |birth_date=February 1945 | ||
|birth_place= | |birth_place= | ||
|death_date= | |death_date= | ||
| Line 10: | Line 12: | ||
|constitutes=businessman | |constitutes=businessman | ||
}} | }} | ||
| + | '''Lodewijk J. R. de Vink''' is a Dutch-American [[Big Pharma]]-executive.<ref name=roche>https://www.roche.com/about/governance/ec-bod-former/lodewijk-devink/</ref> | ||
| + | |||
| + | ==Education== | ||
| + | He took a Bachelor of Business Administration from [[Washburn University]] in [[1968]] and a Master of Business Administration from the [[American University/Kogod School of Business|American University, Netherlands School of Business]] in [[1969]].<ref name=roche/> | ||
| + | |||
| + | ==Career== | ||
| + | He stared his career for [[Big Pharma]] in [[1969]], when he was hired by [[Schering-Plough]], where he worked until [[1988]]. From 1988 until 2000 he worked for [[Warner-Lambert Company]], as Chairman of the Board, President and Chief Executive Officer 1999-2000.<ref name=roche/> In the end of the [[1990s]], Warner–Lambert formed an alliance with Pfizer to bring its [[statin]] drug Lipitor to market. Lipitor, launched in January [[1997], became the largest-selling pharmaceutical of any kind worldwide, reaching $1B in domestic sales within its first twelve months on the market.<ref> Koberstein, Wayne, "Master Launchers", Pharmaceutical Executive, May 1998.</ref> The company merged with [[Pfizer]] in 2000.<ref>https://www.pfizer.com/about/history/pfizer_warner_lambert</ref> | ||
| + | |||
| + | 2000-2002 he worked for [[Credit Suisse First Boston]] as Chairman of Global Health Care Partners. Since 2003 Founding member and consultant for [[Blackstone Healthcare Partners, LLC]]. | ||
| + | |||
| + | ==Board memberships== | ||
| + | He has been a board member of the [[Pharmaceutical Research and Manufacturers of America]] (PhRMA; Chairman in 1995), The [[International Federation of Pharmaceutical Manufacturers Associations]] (IFPMA; Chairman 1998-1999), [[Trilateral Commission]], The [[Business Roundtable]], The [[French American Business Council]], [[Royal Ahold]]; [[Verizon]], U.S.-Chair of the 1998 TransAtlantic Business Dialogue (TABD). In 1990 he was appointed to the President's Export Council.<ref name=roche/> | ||
| + | |||
| + | He is a member of [[Sotheby]]'s International Advisory Board, a member of European Advisory Council of [[Rothschild & Cie]] and a member of the Board of Directors of the [[New York Philharmonic]]. | ||
| + | |||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
| − | |||
Latest revision as of 03:22, 1 March 2023
 Lodewijk J. R. de Vink     (businessman) | |
|---|---|
| Born | February 1945 |
| Nationality | Dutch, US |
| Alma mater | Washburn University, Nyenrode Business University, American University/Kogod School of Business |
| Member of | Trilateral Commission |
Dutch Bilderberger Big Pharma executive | |
Lodewijk J. R. de Vink is a Dutch-American Big Pharma-executive.[1]
Education
He took a Bachelor of Business Administration from Washburn University in 1968 and a Master of Business Administration from the American University, Netherlands School of Business in 1969.[1]
Career
He stared his career for Big Pharma in 1969, when he was hired by Schering-Plough, where he worked until 1988. From 1988 until 2000 he worked for Warner-Lambert Company, as Chairman of the Board, President and Chief Executive Officer 1999-2000.[1] In the end of the 1990s, Warner–Lambert formed an alliance with Pfizer to bring its statin drug Lipitor to market. Lipitor, launched in January [[1997], became the largest-selling pharmaceutical of any kind worldwide, reaching $1B in domestic sales within its first twelve months on the market.[2] The company merged with Pfizer in 2000.[3]
2000-2002 he worked for Credit Suisse First Boston as Chairman of Global Health Care Partners. Since 2003 Founding member and consultant for Blackstone Healthcare Partners, LLC.
Board memberships
He has been a board member of the Pharmaceutical Research and Manufacturers of America (PhRMA; Chairman in 1995), The International Federation of Pharmaceutical Manufacturers Associations (IFPMA; Chairman 1998-1999), Trilateral Commission, The Business Roundtable, The French American Business Council, Royal Ahold; Verizon, U.S.-Chair of the 1998 TransAtlantic Business Dialogue (TABD). In 1990 he was appointed to the President's Export Council.[1]
He is a member of Sotheby's International Advisory Board, a member of European Advisory Council of Rothschild & Cie and a member of the Board of Directors of the New York Philharmonic.
Events Participated in
| Event | Start | End | Location(s) | Description |
|---|---|---|---|---|
| Bilderberg/1998 | 14 May 1998 | 17 May 1998 | Scotland Turnberry | The 46th Bilderberg meeting, held in Scotland, chaired by Peter Carrington |
| Bilderberg/2000 | 1 June 2000 | 4 June 2000 | Belgium Brussels Genval | The 48th Bilderberg, 94 guests |
| Bilderberg/2002 | 30 May 2002 | 2 June 2002 | US Virginia Chantilly Westfields Marriott | The 50th Bilderberg, held at Chantilly, Virginia. |
References
- ↑ a b c d https://www.roche.com/about/governance/ec-bod-former/lodewijk-devink/
- ↑ Koberstein, Wayne, "Master Launchers", Pharmaceutical Executive, May 1998.
- ↑ https://www.pfizer.com/about/history/pfizer_warner_lambert
